121 related articles for article (PubMed ID: 22746987)
1. Predictors of symptomatic remission in first-episode psychosis outpatients treated with quetiapine: a naturalistic study.
Gade K; Köhler J; Klein P; Falkai P; Wobrock T
Int J Psychiatry Clin Pract; 2013 Jun; 17(2):148-53. PubMed ID: 22746987
[TBL] [Abstract][Full Text] [Related]
2. Achieving symptomatic remission in out-patients with schizophrenia--a naturalistic study with quetiapine.
Wobrock T; Köhler J; Klein P; Falkai P
Acta Psychiatr Scand; 2009 Aug; 120(2):120-8. PubMed ID: 19392812
[TBL] [Abstract][Full Text] [Related]
3. [Minor neurological and physical anomalies in patients with first-episode psychosis].
Mhalla A; Boussaïd N; Gassab L; Gaha L; Mechri A
Encephale; 2013 Jun; 39(3):149-54. PubMed ID: 23095597
[TBL] [Abstract][Full Text] [Related]
4. An early improvement in depressive symptoms predicts symptomatic remission of schizophrenia treated with quetiapine: a multicenter, 4-week case-control study.
Chou YH; Chiu NM; Yang TT; Feng J; Chan CC; Lee HK;
Int Clin Psychopharmacol; 2013 Sep; 28(5):255-60. PubMed ID: 23820333
[TBL] [Abstract][Full Text] [Related]
5. Dosing quetiapine in drug-naive first-episode psychosis: a controlled, double-blind, randomized, single-center study investigating efficacy, tolerability, and safety of 200 mg/day vs. 400 mg/day of quetiapine fumarate in 141 patients aged 15 to 25 years.
Berger GE; Proffitt TM; McConchie M; Kerr M; Markulev C; Yuen HP; O'Donnell C; Lubman D; Polari A; Wood S; Amminger PG; McGorry PD
J Clin Psychiatry; 2008 Nov; 69(11):1702-14. PubMed ID: 19036233
[TBL] [Abstract][Full Text] [Related]
6. The efficacy and safety of quetiapine for treatment of geriatric psychosis.
Yang CH; Tsai SJ; Hwang JP
J Psychopharmacol; 2005 Nov; 19(6):661-6. PubMed ID: 16272189
[TBL] [Abstract][Full Text] [Related]
7. Prediction of remission and recovery in young people presenting with first-episode psychosis in Hong Kong: a 3-year follow-up study.
Chang WC; Tang JY; Hui CL; Lam MM; Chan SK; Wong GH; Chiu CP; Chen EY
Aust N Z J Psychiatry; 2012 Feb; 46(2):100-8. PubMed ID: 22311526
[TBL] [Abstract][Full Text] [Related]
8. One-year functional outcomes of naturalistically treated patients with schizophrenia.
Spellmann I; Riedel M; Schennach R; Seemüller F; Obermeier M; Musil R; Jäger M; Schmauß M; Laux G; Pfeiffer H; Naber D; Schmidt LG; Gaebel W; Klosterkötter J; Heuser I; Maier W; Lemke MR; Rüther E; Klingberg S; Gastpar M; Möller HJ
Psychiatry Res; 2012 Aug; 198(3):378-85. PubMed ID: 22421065
[TBL] [Abstract][Full Text] [Related]
9. Symptomatic remission and cognitive impairment in first-episode schizophrenia: a prospective 3-year follow-up study.
Chang WC; Ming Hui CL; Yan Wong GH; Wa Chan SK; Ming Lee EH; Hai Chen EY
J Clin Psychiatry; 2013 Nov; 74(11):e1046-53. PubMed ID: 24330905
[TBL] [Abstract][Full Text] [Related]
10. Symptomatic and functional remission of subjects at clinical high risk for psychosis: a 2-year naturalistic observational study.
Lee TY; Kim SN; Correll CU; Byun MS; Kim E; Jang JH; Kang DH; Yun JY; Kwon JS
Schizophr Res; 2014 Jul; 156(2-3):266-71. PubMed ID: 24815568
[TBL] [Abstract][Full Text] [Related]
11. Sexual functioning associated with quetiapine switch vs. risperidone continuation in outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind pilot trial.
Byerly MJ; Nakonezny PA; Rush AJ
Psychiatry Res; 2008 May; 159(1-2):115-20. PubMed ID: 18295343
[TBL] [Abstract][Full Text] [Related]
12. Symptomatic and functional remission in patients with first-episode psychosis.
Verma S; Subramaniam M; Abdin E; Poon LY; Chong SA
Acta Psychiatr Scand; 2012 Oct; 126(4):282-9. PubMed ID: 22616617
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of ziprasidone in the treatment of first-episode psychosis: an 8-week, open-label, multicenter trial.
Zhao T; Park TW; Yang JC; Huang GB; Kim MG; Lee KH; Chung YC
Int Clin Psychopharmacol; 2012 Jul; 27(4):184-90. PubMed ID: 22426471
[TBL] [Abstract][Full Text] [Related]
14. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
McIntyre RS; Konarski JZ; Jones M; Paulsson B
J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773
[TBL] [Abstract][Full Text] [Related]
15. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial.
Cutler AJ; Datto C; Nordenhem A; Minkwitz M; Acevedo L; Darko D
Clin Ther; 2011 Nov; 33(11):1643-58. PubMed ID: 22054797
[TBL] [Abstract][Full Text] [Related]
16. Trajectories and antecedents of treatment response over time in early-episode psychosis.
Levine SZ; Rabinowitz J
Schizophr Bull; 2010 May; 36(3):624-32. PubMed ID: 18849294
[TBL] [Abstract][Full Text] [Related]
17. Quetiapine in adolescents with non-affective psychotic disorders: an open-label trial.
Holzer L; Preuss U; Baumgartner L; Jaugey L; Urben S; Halfon O; Baumann P
Pharmacopsychiatry; 2011 May; 44(3):87-95. PubMed ID: 21318938
[TBL] [Abstract][Full Text] [Related]
18. Early intervention with second-generation antipsychotics in first-episode psychosis: results of an 8-week naturalistic study.
Josiassen RC; Shaughnessy RA; Filymer DM; Donohue AM; Kacso M; Finkel N; Curtis J; Audino B; Skuban N
Early Interv Psychiatry; 2010 Feb; 4(1):57-63. PubMed ID: 20199481
[TBL] [Abstract][Full Text] [Related]
19. Quetiapine in the treatment of psychotic adolescents: a case series of 23 patients with severe early onset psychosis.
Beer F; Heinrich H; Springer S; Rüth U; Freisleder FJ
World J Biol Psychiatry; 2007; 8(1):38-41. PubMed ID: 17366348
[TBL] [Abstract][Full Text] [Related]
20. Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study.
Paleacu D; Barak Y; Mirecky I; Mazeh D
Int J Geriatr Psychiatry; 2008 Apr; 23(4):393-400. PubMed ID: 17879256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
